OPK News and Press, Opko Health Inc. From 05/03/24

MIAMI, May 03, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three months ended March 31, 2024 after the close of the U.S. financial markets on Tuesday, May 7, 2024. OPKO’s senior management will provide a business upda...

Enact Holdings Inc. (ACT) is expected to report $0.99 for Q1 2024 FormFactor Inc. (FORM) is expected to report $0.09 for Q1 2024 SAAB AB - Class B (SAABF) is expected to report for quarter end 2024-03-31 Lumos Pharma Inc. (LUMO) is expected to report $-1.21 for Q1 2024 Axis Capita...

2024-04-01 02:20:59 ET Summary LabCorp's shares have been trading around $200 for several years, but the company expects growth to return in 2024. LabCorp has acquired BioReference Health's laboratory testing business for $237 million, adding to its diagnostics segment. LabCor...

2024-03-28 08:42:18 ET More on Labcorp, OPKO Health, etc. OPKO Health, Inc. (OPK) Q4 2023 Earnings Call Transcript Laboratory Corporation of America Holdings (LH) Q4 2023 Earnings Call Transcript Laboratory Corporation of America Holdings 2023 Q4 - Results - Earnings...

Labcorp Announces Acquisition of Select Assets of BioReference Health's Diagnostics Business PR Newswire Transaction to enhance Labcorp's laboratory services network and expand access to the company's high-quality clinical laboratory services BURLINGTON, N.C. ...

JERUSALEM, March 20, 2024 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the development of orally delivered peptides, announced today positive pharmacokinetic results from its collaborative research combining a proprietary ...

• Study delivers first clinical safety and pharmacokinetic data as proof of concept for the use of multispecific antibodies in humans • Candidate showed similar half-life to standard monoclonal antibodies and minimal anti-drug antibodies WESTON, Mass., March 05, 202...

NextPlat Opens OPKO Health-Branded Storefront on Alibaba's Tmall Global Platform in China on March 1st PR Newswire New Health and Wellness E-Commerce Storefront Launches After Receiving All Required Approvals with Initial Selection of OPKO Health Products COCONU...

2024-02-27 21:00:19 ET Image source: The Motley Fool. Opko Health (NASDAQ: OPK) Q4 2023 Earnings Call Feb 27, 2024 , 4:30 p.m. ET Operator Continue reading For further details see: Opko Health (OPK) Q4 2023 Earnings Call Transcript

MIAMI, Feb. 27, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three and 12 months ended December 31, 2023. Business highlights from the fourth quarter and subsequent weeks included the following: ModeX advanced...